Lagniau’s team believes the main target ought to address individuals with a history of amphibole exposure with no signs of asbestos-related health conditions. High-risk people may be monitored with breathomics, and if they're later diagnosed with carcinoma or another asbestos-related sickness, researchers will higher confirm the biological changes that occurred. While this won’t stop the event of carcinoma, it may probably result in detection before symptoms seem, once the cancer is localized and additional life-extending treatment choices area unit attainable. It may revolutionize the diagnostic method, that currently depends on imaging tests and biopsies. “Cancer could be a sickness that affects individuals in each layer of society and that we, scientists, have the duty to use our data on human health in exploring new ways that to enhance cancer management,” Lagniau wrote. “Therefore, future studies ought to specialize in the at-risk population, consisting of individuals being [occupationally] exposed to amphibole with a latency time of a minimum of twenty years once exposure.”